Sky-high for charity
Fasha Mahjoor, Founder and CEO of Phenomenex (Torrance, California, USA), will leap off the 87th floor of The Shard in London on 3 September to raise money for The Outward Bound Trust, an educational charity.
Fasha Mahjoor — Founder and CEO of Phenomenex (Torrance, California, USA) — will leap off the 87th floor of The Shard in London on 3 September to raise money for The Outward Bound Trust, an educational charity. Accompanied by a group, he will abseil down 1,056 feet of the tallest building in Europe: The highest ever attempted descent by a civilian.
Mahjoor’s goal is to raise a minimum of £150,000/€190,000 of which he has personally donated the initial £20,000/€25,000.Led by the Chairman of The Outward Bound Trust, His Royal Highness The Duke of York, Prince Andrew, the charity has enabled over one million underprivileged youths to participate in outdoor programmes, providing important lessons in responsibility, teamwork and leadership.
Mahjoor commented: “Some may think I’ve gone a bit mad to undertake this challenge. But being that it’s for such a wonderful cause that I so very much believe in, I couldn’t possibly turn down the opportunity. To raise money to ensure that this programme continues to impact the lives of many more young people for years to come is simply a privilege.”
This story originally appeared in The Column. Click here to view that issue.
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
